NOVARTIS AG (NVS) Income statement

Market cap

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	51,900	47,498	48,659	51,626	50,545	45,440	50,317	54,532
Revenue growth (%)	-
Gross profit	34,759	34,252	34,777	37,010	36,342	34,188	38,895	42,975
Gross margin (%)
Research & development	9,074	9,402	8,980	9,540	9,996	11,371	10,022	11,200
Selling, general & administrative	16,471	14,369	14,197	14,886	14,253	12,517	12,566	13,248
Operating margin (%)
Operating income	8,169	9,086	10,152	11,689	9,197	9,769	14,544	17,644
Income before tax	13,835	8,940	9,878	26,137	8,371	9,123	13,640	16,352
Pretax margin (%)	26.7	18.8	20.3	50.6	16.6	20.1	27.1	30
Net income	12,614	11,737	8,071	24,018	6,955	14,854	11,939	13,967
Net income margin (%)